Published in J Infect Dis on May 22, 2001
Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: a prospective cohort analysis among African couples. PLoS Med (2012) 2.06
The aetiology of bacterial vaginosis. J Appl Microbiol (2011) 1.22
Short-chain fatty acids induce pro-inflammatory cytokine production alone and in combination with toll-like receptor ligands. Am J Reprod Immunol (2011) 1.01
Susceptibility of Gardnerella vaginalis biofilms to natural antimicrobials subtilosin, ε-poly-L-lysine, and lauramide arginine ethyl ester. Infect Dis Obstet Gynecol (2012) 0.82
The effects of chronic binge alcohol on the genital microenvironment of simian immunodeficiency virus-infected female rhesus macaques. AIDS Res Hum Retroviruses (2014) 0.80
Oleate lipase activity in Gardnerella vaginalis and reconsideration of existing biotype schemes. BMC Microbiol (2009) 0.80
Co-infection of human immunodeficiency virus and sexually transmitted infections in circumcised and uncircumcised cases in India. Indian J Sex Transm Dis (2015) 0.75
Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations. Am J Obstet Gynecol (1998) 3.51
Role of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-1. J Exp Med (1995) 2.12
Degenerative lumbar spondylolisthesis. A meta-analysis of literature 1970-1993. Spine (Phila Pa 1976) (1994) 1.75
Defense factors of vaginal lactobacilli. Am J Obstet Gynecol (2001) 1.68
Hydroxyapatite augmentation of the porous coating improves fixation of tibial components. A randomised RSA study in 116 patients. J Bone Joint Surg Br (1998) 1.66
Reduced fertility in female mice lacking copper-zinc superoxide dismutase. J Biol Chem (1998) 1.63
HIV multidisciplinary teams work: support services improve access to and retention in HIV primary care. AIDS Care (2002) 1.63
Human immunodeficiency virus type 1 incorporates both glycosyl phosphatidylinositol-anchored CD55 and CD59 and integral membrane CD46 at levels that protect from complement-mediated destruction. J Gen Virol (1997) 1.59
Efficacy of vitamin B6 and magnesium in the treatment of autism: a methodology review and summary of outcomes. J Autism Dev Disord (1995) 1.49
Neuroleukin: a lymphokine product of lectin-stimulated T cells. Science (1986) 1.44
Comparison of the activities of penicillin G and new beta-lactam antibiotics against clinical isolates of Bacteroides species. Antimicrob Agents Chemother (1984) 1.40
Anion gap determination in preeclampsia. Obstet Gynecol (1998) 1.39
Susceptibility of HIV-1 plasma virus to complement-mediated lysis. Evidence for a role in clearance of virus in vivo. J Immunol (1996) 1.39
American Society of Pediatric Otolaryngology news. Arch Otolaryngol Head Neck Surg (1994) 1.38
Effects of pudendal nerve injury in the female rat. Neurourol Urodyn (2000) 1.36
CD4-Negative cells bind human immunodeficiency virus type 1 and efficiently transfer virus to T cells. J Virol (2000) 1.31
Interaction of mannose-binding lectin with primary isolates of human immunodeficiency virus type 1. J Gen Virol (2000) 1.30
T cell receptor excision circle (TREC) content following maximum HIV suppression is equivalent in HIV-infected and HIV-uninfected individuals. AIDS (2001) 1.29
Gardnerella vaginalis isolated from patients with bacterial vaginosis and from patients with healthy vaginal ecosystems. Clin Infect Dis (2001) 1.24
Repair of full thickness rotator cuff tears. Gender, age, and other factors affecting outcome. Clin Orthop Relat Res (1999) 1.24
Isolation of the Bacillus subtilis antimicrobial peptide subtilosin from the dairy product-derived Bacillus amyloliquefaciens. J Appl Microbiol (2007) 1.23
Outcome after rectovaginal fascia reattachment for rectocele repair. Am J Obstet Gynecol (1999) 1.19
Current trends in the management of adamantinoma of long bones. An international study. J Bone Joint Surg Am (2000) 1.18
Typhoid fever in pregnancy. A case report. J Reprod Med (1990) 1.16
Bacterial vaginosis-associated microflora isolated from the female genital tract activates HIV-1 expression. J Acquir Immune Defic Syndr (1999) 1.15
Taste changes experienced by patients receiving chemotherapy. Oncol Nurs Forum (1999) 1.13
Activation of human immunodeficiency virus type 1 expression by Gardnerella vaginalis. J Infect Dis (1999) 1.11
Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer. J Clin Oncol (1994) 1.11
Childhood leukemia: central nervous system abnormalities during and after treatment. AJNR Am J Neuroradiol (1996) 1.09
Host cell components affect the sensitivity of HIV type 1 to complement-mediated virolysis. AIDS Res Hum Retroviruses (1994) 1.09
Transvaginal electrical stimulation for female urinary incontinence. Am J Obstet Gynecol (1997) 1.09
The analgesic effects of subhypnotic doses of propofol in human volunteers with experimentally induced tourniquet pain. AANA J (2001) 1.08
Immune complexes containing human immunodeficiency virus type 1 primary isolates bind to lymphoid tissue B lymphocytes and are infectious for T lymphocytes. J Virol (2000) 1.08
In-vitro and in-vivo activity of parenterally administered beta-lactam antibiotics against Chlamydia trachomatis. Sex Transm Dis (1986) 1.07
Induction of human immunodeficiency virus type 1 expression by anaerobes associated with bacterial vaginosis. J Infect Dis (2000) 1.07
Intraspinal morphine for chronic pain: a retrospective, multicenter study. J Pain Symptom Manage (1996) 1.07
The microbiology of post-cesarean wound morbidity. Obstet Gynecol (1993) 1.05
Topical capsaicin in the management of HIV-associated peripheral neuropathy. J Pain Symptom Manage (2000) 1.05
Retrospective evaluation of the isolation and identification of herpes simplex virus with Cultureset and human fibroblasts. J Clin Microbiol (1985) 1.04
The role of bacterial vaginosis in infection after major gynecologic surgery. Infect Dis Obstet Gynecol (1999) 1.04
Mechanisms of resistance of HIV-1 primary isolates to complement-mediated lysis. Virology (1998) 1.03
Complement can neutralize HIV-1 plasma virus by a C5-independent mechanism. Virology (1998) 1.03
Susceptibility of female pelvic pathogens to oral antibiotic agents in patients who develop postpartum endometritis. Am J Obstet Gynecol (1991) 1.02
Accuracy and precision of radiostereometric analysis in the measurement of THR femoral component translations: human and canine in vitro models. J Orthop Res (2001) 1.01
NATURAL ANTIMICROBIALS AND THEIR ROLE IN VAGINAL HEALTH: A SHORT REVIEW. Int J Probiotics Prebiotics (2008) 1.00
Barriers to cancer pain relief: fear of tolerance and addiction. J Pain Symptom Manage (1998) 1.00
Piperacillin and tazobactam versus clindamycin and gentamicin in the treatment of hospitalized women with pelvic infection. The Piperacillin/tazobactam Study Group. Obstet Gynecol (1994) 0.99
Complement and antibody mediate enhancement of HIV infection by increasing virus binding and provirus formation. AIDS (1991) 0.99
Detection of HLA-DR associated with monocytotropic, primary, and plasma isolates of human immunodeficiency virus type 1. J Virol (1997) 0.99
Development of wound infection or separation after cesarean delivery. Prospective evaluation of 2,431 cases. J Reprod Med (1995) 0.98
Pelvic inflammatory disease. Key treatment issues and options. JAMA (1991) 0.98
Isolation of vancomycin-resistant Staphylococcus aureus in a teaching hospital in Tehran. J Hosp Infect (2007) 0.98
Multicenter randomized trial of ofloxacin versus cefoxitin and doxycycline in outpatient treatment of pelvic inflammatory disease. Ambulatory PID Research Group. South Med J (1993) 0.98
A comparison of women with primary and recurrent pelvic prolapse. Am J Obstet Gynecol (1999) 0.97
Effect of preoperative voiding mechanism on success rate of autologous rectus fascia suburethral sling procedure. Obstet Gynecol (1998) 0.97
Short-course parenteral antibiotic therapy for pyelonephritis in pregnancy. South Med J (1984) 0.97
Group B beta-hemolytic streptococci and puerperal infections. Am J Obstet Gynecol (1981) 0.97
Safety study of an antimicrobial peptide lactocin 160, produced by the vaginal Lactobacillus rhamnosus. Infect Dis Obstet Gynecol (2007) 0.96
MR of the cerebral operculum: topographic identification and measurement of interopercular distances in healthy infants and children. AJNR Am J Neuroradiol (1995) 0.95
Pyelonephritis and sepsis due to Staphylococcus saprophyticus. J Infect Dis (1987) 0.95
Antimicrobial protein produced by vaginal Lactobacillus acidophilus that inhibits Gardnerella vaginalis. Infect Dis Obstet Gynecol (2001) 0.94
Abdominal wall Actinomyces abscess associated with an intrauterine device. A case report. J Reprod Med (1991) 0.94
2',5'-oligoadenylate synthetase, neopterin and beta 2-microglobulin in asymptomatic HIV-infected individuals. AIDS (1991) 0.93
Evaluation of thymopoiesis using T cell receptor excision circles (TRECs): differential correlation between adult and pediatric TRECs and naïve phenotypes. Clin Immunol (2000) 0.93
B lymphocytes in lymph nodes and peripheral blood are important for binding immune complexes containing HIV-1. Immunology (1999) 0.92
Responsiveness of quality of life measurements to change after reconstructive pelvic surgery. Am J Obstet Gynecol (2001) 0.92
Bacteriocin susceptibility of Gardnerella vaginalis and its relationship to biotype, genotype, and metronidazole susceptibility. Am J Obstet Gynecol (2001) 0.92
Predominant sexually transmitted diseases among different age and ethnic groups of indigent sexually active adolescents attending a family planning clinic. J Adolesc Health Care (1988) 0.92
Interaction of non-antibody factors with HIV in plasma. AIDS (1993) 0.92
The anatomic and functional variability of rectoceles in women. Int Urogynecol J Pelvic Floor Dysfunct (1999) 0.92
Predicting the risk of pressure ulcers in critically ill patients. Am J Crit Care (1999) 0.91
Complement-mediated, antibody-dependent neutralizing titers of sera from asymptomatic and symptomatic HIV-infected individuals. AIDS (1992) 0.91
Evaluation of immunologic markers in cervicovaginal fluid of HIV-infected and uninfected women: implications for the immunologic response to HIV in the female genital tract. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 0.91
L-ficolin binding and lectin pathway activation by acetylated low-density lipoprotein. Clin Exp Immunol (2007) 0.91
The radiographic joint space width in clinically normal hips: effects of age, gender and physical parameters. Osteoarthritis Cartilage (2003) 0.90
Contributions of bone density and geometry to the strength of the human second metatarsal. Bone (2000) 0.90
Chlamydia trachomatis infection in women. J Reprod Med (1985) 0.90
In vivo measurement of the subchondral bone thickness of lumbar facet joint using magnetic resonance imaging. Osteoarthritis Cartilage (2010) 0.90
The inhibitory effect of clindamycin on Lactobacillus in vitro. Infect Dis Obstet Gynecol (2001) 0.89
Occipitocervical stabilization for myelopathy in patients with rheumatoid arthritis. Implications of not bone-grafting. J Bone Joint Surg Am (2000) 0.89
Association of indicators of bacterial vaginosis with a female genital tract factor that induces expression of HIV-1. AIDS (1999) 0.89
Transfer of host T-cell membrane HLA-DR and CD25 to target cells by human retroviruses. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 0.89
Nodular fasciitis as a vascular neck mass. AJNR Am J Neuroradiol (1996) 0.89
A human immunodeficiency virus (HIV)-inducing factor from the female genital tract activates HIV-1 gene expression through the kappaB enhancer. J Infect Dis (1998) 0.88
Premarket evaluation of Monofluor reagent for detecting Chlamydia trachomatis in adolescent outpatients. Genitourin Med (1988) 0.88
In vivo decrease in the expression of complement receptor 2 on B-cells in HIV infection. AIDS (1993) 0.88
MR of the cerebral operculum: abnormal opercular formation in infants and children. AJNR Am J Neuroradiol (1996) 0.87
Isolation of Mycoplasma species and Ureaplasma urealyticum from obstetrical and gynecological patients by using commercially available medium formulations. J Clin Microbiol (1986) 0.87
Favorable outcome after treatment with amantadine and ribavirin in a pregnancy complicated by influenza pneumonia. A case report. J Reprod Med (1988) 0.87
Phenotypic analysis of complement receptor 2+ T lymphocytes: reduced expression on CD4+ cells in HIV-infected persons. Immunology (1992) 0.87